141 related articles for article (PubMed ID: 29563804)
21. Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.
Wei IH; Harmon CM; Arcerito M; Cheng DF; Minter RM; Simeone DM
Ann Surg; 2014 Dec; 260(6):1088-94. PubMed ID: 25389924
[TBL] [Abstract][Full Text] [Related]
22. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585
[TBL] [Abstract][Full Text] [Related]
24. Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
Sun J; Ling B; Xu X; Ma R; Li G; Cao X; Ling W; Yang Z; Hoffman RM; Lu J
Anticancer Res; 2016 Mar; 36(3):869-75. PubMed ID: 26976973
[TBL] [Abstract][Full Text] [Related]
25. Impact of liver kinase B1 on p53 and survivin and its correlation with prognosis in gastric cancer.
Li W; Luo S; Ma G; Wang L
Onco Targets Ther; 2019; 12():1439-1445. PubMed ID: 30863111
[TBL] [Abstract][Full Text] [Related]
26. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
27. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
[TBL] [Abstract][Full Text] [Related]
28. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
29. Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
Liu XK; Zhang XR; Zhong Q; Li MZ; Liu ZM; Lin ZR; Wu D; Zeng MS
J Transl Med; 2013 Mar; 11():59. PubMed ID: 23497344
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.
Han X; Xu X; Jin D; Wang D; Ji Y; Lou W
Pancreas; 2014 May; 43(4):526-31. PubMed ID: 24658317
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
[TBL] [Abstract][Full Text] [Related]
33. Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors.
Shanahan MA; Salem A; Fisher A; Cho CS; Leverson G; Winslow ER; Weber SM
J Surg Res; 2016 Mar; 201(1):38-43. PubMed ID: 26850182
[TBL] [Abstract][Full Text] [Related]
34. [Expression Level of LKB1 Gene in Patients with Acute Lymphoblastic Leukemia and Its Correlation with Illness Condition].
Han F; Lai TW; Li H; Tan WM; Wu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):464-469. PubMed ID: 32319380
[TBL] [Abstract][Full Text] [Related]
35. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
[No Abstract] [Full Text] [Related]
36. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.
Conde E; Suarez-Gauthier A; García-García E; Lopez-Rios F; Lopez-Encuentra A; García-Lujan R; Morente M; Sanchez-Verde L; Sanchez-Cespedes M
Hum Pathol; 2007 Sep; 38(9):1351-60. PubMed ID: 17521700
[TBL] [Abstract][Full Text] [Related]
37. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.
Jing Y; Zhou Q; Zhu H; Zhang Y; Song Y; Zhang X; Huang X; Yang Y; Ni Y; Hu Q
Oncol Lett; 2019 Jan; 17(1):974-980. PubMed ID: 30655856
[TBL] [Abstract][Full Text] [Related]
38. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
39. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]